Whittier Trust CO Akero Therapeutics, Inc. Transaction History
Whittier Trust CO
- $7.37 Billion
- Q3 2024
A detailed history of Whittier Trust CO transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Whittier Trust CO holds 157 shares of AKRO stock, worth $4,389. This represents 0.0% of its overall portfolio holdings.
Number of Shares
157
Previous 157
-0.0%
Holding current value
$4,389
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AKRO
# of Institutions
190Shares Held
73.8MCall Options Held
241KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.9MShares$221 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$198 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$166 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$156 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$146 Million4.29% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.3B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...